2/10
12:44 pm
nktr
Rating for NKTR
Medium
Report
Rating for NKTR
2/10
12:00 pm
nktr
Nektar Therapeutics (NASDAQ:NKTR) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Nektar Therapeutics (NASDAQ:NKTR) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/10
12:00 pm
nktr
Nektar Therapeutics (NASDAQ:NKTR) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
Medium
Report
Nektar Therapeutics (NASDAQ:NKTR) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.
2/10
11:26 am
nktr
Nektar upgraded to Outperform from Market Perform at William Blair
Medium
Report
Nektar upgraded to Outperform from Market Perform at William Blair
2/10
11:26 am
nktr
Nektar upgraded to Outperform from Market Perform at William Blair
Medium
Report
Nektar upgraded to Outperform from Market Perform at William Blair
1/29
12:30 pm
nktr
Nektar Therapeutics (NASDAQ:NKTR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $118.00 price target on the stock.
Low
Report
Nektar Therapeutics (NASDAQ:NKTR) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $118.00 price target on the stock.
1/29
11:54 am
nktr
Rating for NKTR
Low
Report
Rating for NKTR
11/26
02:13 pm
nktr
Rating for NKTR
Low
Report
Rating for NKTR
11/26
02:13 pm
nktr
Rating for NKTR
Low
Report
Rating for NKTR
11/26
01:29 pm
nktr
Rating for NKTR
Low
Report
Rating for NKTR
11/26
01:29 pm
nktr
Rating for NKTR
Low
Report
Rating for NKTR
11/26
09:11 am
nktr
Nektar Therapeutics (NASDAQ:NKTR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $102.00 price target on the stock.
Medium
Report
Nektar Therapeutics (NASDAQ:NKTR) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $102.00 price target on the stock.